Vivos Inc (RDGL) Financial Statements (2024 and earlier)

Company Profile

Business Address 719 JADWIN AVENUE
RICHLAND, WA 99352
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,7061,6069042058
Cash and cash equivalents1,7061,6069042058
Receivables11     
Inventory, net of allowances, customer advances and progress billings      8
Inventory      8
Prepaid expense26283423117
Other undisclosed current assets      (8)
Total current assets:1,7431,634938441615
Noncurrent Assets
Property, plant and equipment 2     
Intangible assets, net (including goodwill)  14142470 
Intangible assets, net (excluding goodwill)  14142470 
Other noncurrent assets      1
Other undisclosed noncurrent assets (2)(14)(14)(24)(70) 
Total noncurrent assets:      1
TOTAL ASSETS:1,7431,634938441616
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:82167362512795841
Interest and dividends payable 1019360347
Employee-related liabilities 661001186
Other undisclosed accounts payable and accrued liabilities82167195319724408
Debt   107100542,563
Due to related parties  26926939384
Other undisclosed current liabilities  16764371490
Total current liabilities:821679061,5249594,278
Noncurrent Liabilities
Total liabilities:821679061,5249594,278
Equity
Equity, attributable to parent, including:1,6611,46732(1,480)(942)(4,262)
Preferred stock      4
Common stock3633442921851,30866
Additional paid in capital71,21868,57364,55261,72258,98859,956
Accumulated deficit(79,556)(77,086)(74,558)(73,601)(71,991)(64,288)
Other undisclosed equity, attributable to parent9,6379,6379,74610,21510,753 
Total equity:1,6611,46732(1,480)(942)(4,262)
TOTAL LIABILITIES AND EQUITY:1,7431,634938441616

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues3615710184
Revenue, net4
Other income     18 
Cost of revenue
(Cost of Goods and Services Sold)
(29)(12)(6)(6)  
Gross profit:8313184
Operating expenses(2,525)(2,505)(674)(1,333)(2,490)(2,621)
Other undisclosed operating loss     (18) 
Operating loss:(2,518)(2,502)(673)(1,330)(2,490)(2,617)
Nonoperating income (expense)48(26)(284)(280)(5,213)(3,802)
Interest and debt expense 48(137)(287)(19)606(310)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes   28719(606)310
Loss from continuing operations before equity method investments, income taxes:(2,423)(2,665)(957)(1,610)(7,703)(6,419)
Other undisclosed income (loss) from continuing operations before income taxes (48)137    
Loss from continuing operations:(2,470)(2,528)(957)(1,610)(7,703)(6,419)
Loss before gain (loss) on sale of properties:(2,528)(957)(1,610)(7,703)(6,419)
Net loss available to common stockholders, diluted:(2,470)(2,528)(957)(1,610)(7,703)(6,419)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(2,470)(2,528)(957)(1,610)(7,703)(6,419)
Comprehensive loss, net of tax, attributable to parent:(2,470)(2,528)(957)(1,610)(7,703)(6,419)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: